Search results
Results from the WOW.Com Content Network
A product key is required to proceed and use Windows 95. In one form, product activation refers to a method invented by Ric Richardson and patented (U.S. patent 5,490,216) by Uniloc where a software application hashes hardware serial numbers and an ID number specific to the product's license (a product key) to
On Windows 10 and Windows 11, the activation process can also generate a "digital entitlement", which allows the operating system's hardware and license status to be saved to the activation servers, so that the operating system's license can automatically be restored after a clean installation without the need to enter a product key.
The tool's design is based on a dental impactor, [6] a device that taps dental amalgam into cavities in teeth. [4] Activator I was patented by Activator Methods International on September 26, 1978. [4] [7] [8] Activator II was released, with an added "impedance head", in 1994. [4]
Activator may refer to: Activator (genetics) , a DNA-binding protein that regulates one or more genes by increasing the rate of transcription Activator (phosphor) , a type of dopant used in phosphors and scintillators
The VP64-p65-Rta, or VPR, dCas9 activator was created by modifying an existing dCas9 activator, in which a Vp64 transcriptional activator is joined to the C terminus of dCas9. [1] In the dCas9-VPR protein, the transcription factors p65 and Rta are added to the C terminus of dCas9-Vp64.
A transcriptional activator is a protein (transcription factor) that increases transcription of a gene or set of genes. [1] Activators are considered to have positive control over gene expression, as they function to promote gene transcription and, in some cases, are required for the transcription of genes to occur.
[6] [8] The APC Activator IMP321 (Eftilagimod alpha), a soluble LAG-3 fusion protein, is currently undergoing clinical trials in combination with chemotherapy , or immune checkpoint inhibitors, including the PD-1 monoclonal antibody pembrolizumab, to accelerate the adaptive immune response in several tumor indications. [9] [2] [4]
Peptide-methionine (S)-S-oxide reductase (EC 1.8.4.11, MsrA, methionine sulphoxide reductase A, methionine S-oxide reductase (S-form oxidizing), methionine sulfoxide reductase A, peptide methionine sulfoxide reductase, formerly protein-methionine-S-oxide reductase) is an enzyme with systematic name peptide-L-methionine:thioredoxin-disulfide S-oxidoreductase (L-methionine (S)-S-oxide-forming).